US FDA delays approval for Moderna vax for teens
Moderna also said it will delay filing a request for emergency use authorisation for a smaller dose of the vaccine for younger kids aged six to 11 while the FDA completes its review.
Moderna also said it will delay filing a request for emergency use authorisation for a smaller dose of the vaccine for younger kids aged six to 11 while the FDA completes its review.
"This research confirms that the test we developed is sensitive and safe," said Robert B. Darnell, Professor, and Head of the Laboratory of Molecular Neuro-Oncology.
US President Joe Biden, at a CNN town hall meeting last week, said that children under 12 might have access to a vaccine "soon".
For life to exist along with other molecules and chemicals, cholesterol is most crucial